Search

everythinglearnresearchcommunity

for

Search:↓

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Seborrheic dermatitis and dandruff are often treated with antifungal and anti-inflammatory medications, which can reduce symptoms and yeast growth on the scalp.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

RDW can be a useful marker for inflammation in alopecia areata patients.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Dermoscopy effectively diagnoses and evaluates female hair loss treatment.

White and yellow dots indicate severe female hair loss in dark skin.

A woman with EMS showed unusual skin mucinosis without the typical hard skin syndrome, suggesting EMS can cause skin mucinosis.

Child with rickets improved with a specific vitamin D therapy, but alopecia did not change.

Looking at tissue characteristics isn't reliable for telling apart basal cell carcinoma from certain benign skin tumors.

Non-invasive methods can effectively diagnose and manage alopecia areata.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Talc in street cocaine can cause immune-reactive skin nodules where injected.

Sweat hypersensitivity can cause severe skin issues in horses.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Wnt5a may contribute to psoriasis by reducing skin cell growth, blocking skin cell maturation, and increasing inflammation.